ANGELA VINES: Open Payments
NPI 1942648324 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 53 payments from 15 companies in 2025. Trend: 2023 $1,027 · 2024 $748 · 2025 $1,118
Food & beverage: $1,118
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 13 | $324 |
| E.R. Squibb & Sons, L.L.C. | 6 | $151 |
| Novo Nordisk Inc | 5 | $108 |
| Esperion Therapeutics, Inc. | 5 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Abbott Laboratories | 2 | $54 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $47 |
| PFIZER INC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
Products named: WINREVAIR, CAMZYOS, VERQUVO, NEXLETOL, Wegovy, JARDIANCE, LEQVIO, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across OK — which companies pay providers there.
